Advertisement Chemoswed: Commercial Scale Manufacture of Benserazide Hydrochloride in Main Plant - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
More info about

Chemoswed: Commercial Scale Manufacture of Benserazide Hydrochloride in Main Plant

The necessary regulatory filings, EDMF and CEP, have been made with the relevant authorities. This latest addition to Chemoswed’s commercial line of products is applied in a fixed dose combination with L-dopa, serving to minimise systemic side effects in Parkinson’s disease patients.

Said Carl Andersson, marketing manager at Chemoswed:

Benserazide represents a great business opportunity for us on a pretty poorly supported generics market. While benserazide hydrochloride is rather demanding from a process point of view, our development over the last few years has established a product of superior quality which we are keen to offer to European customers at competitive prices.